NOBILIS HEALTH CORP vs. NVIDIA Corporation
NOBILIS HEALTH CORP (NRTSF) comes out ahead, leading on 1 of 1 compared factors.
Size & Scale
| NRTSF | NVDA | |
|---|---|---|
| Market Cap | — | $5.25 trillion |
| Revenue (TTM) | — | $302.97 billion |
| Net Income (TTM) | — | $192.88 billion |
NRTSF and NVDA split the size & scale factors evenly.
Valuation
| NRTSF | NVDA | |
|---|---|---|
| P/E Ratio | — | 28.37 |
| Price / Book | — | 22.93 |
| Price / Sales | — | 17.33 |
NRTSF and NVDA split the valuation factors evenly.
Profitability
| NRTSF | NVDA | |
|---|---|---|
| Net Margin | — | 63.66% |
| Return on Equity | — | 84.23% |
NRTSF and NVDA split the profitability factors evenly.
Dividend
| NRTSF | NVDA | |
|---|---|---|
| Dividend Yield | 120000000.00% | 0.45% |
| Payout Ratio | — | 12.64 |
NRTSF leads on 1 of 1 dividend factors.
Risk & Sentiment
| NRTSF | NVDA | |
|---|---|---|
| Short Interest | — | 0.07% |
NRTSF and NVDA split the risk & sentiment factors evenly.
Dig deeper: NRTSF overview, NRTSF financials, NVDA overview, NVDA financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.